In its latest draft standard contract for 2025/26, the National Health Service in England has proposed enhanced prescribing requirements “in recognition of the increasing importance of biosimilars in the provision of biological medicines.”
NHS England has proposed enhanced provisions to promote biosimilars
An enhanced requirement for the National Health Service in England to use “best-value biological medicines” whenever possible has been included in a new draft NHS standard contract published by the NHS for 2025/2026.
The NHS said that the measure had been introduced “in recognition of the increasing importance of biosimilars in
